BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27030118)

  • 1. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing CVD in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA.
    Hauk L
    Am Fam Physician; 2016 Feb; 93(3):232-3. PubMed ID: 26926617
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
    Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK; ; ;
    Diabetes Care; 2015 Sep; 38(9):1777-803. PubMed ID: 26246459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.
    Woolf SH; Davidson MB; Greenfield S; Bell HS; Ganiats TG; Hagen MD; Palda VA; Rizza RA; Spann SJ
    J Fam Pract; 2000 May; 49(5):453-60. PubMed ID: 10836779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
    Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK;
    Circulation; 2015 Aug; 132(8):691-718. PubMed ID: 26246173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
    Joseph JJ; Deedwania P; Acharya T; Aguilar D; Bhatt DL; Chyun DA; Di Palo KE; Golden SH; Sperling LS;
    Circulation; 2022 Mar; 145(9):e722-e759. PubMed ID: 35000404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach to reducing cardiovascular risk factors.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S25-36. PubMed ID: 17934391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].
    Pedro-Botet J; ChillarĂ³n JJ; Benaiges D; Flores-Le Roux JA
    Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
    Lund SS; Vaag AA
    Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
    [No Abstract]   [Full Text] [Related]  

  • 17. Slowing cardiovascular disease progression in African-American patients: diabetes management.
    Gavin JR
    J Clin Hypertens (Greenwich); 2004 Apr; 6(4 Suppl 1):26-33. PubMed ID: 15073464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of cardiovascular disease in patients with diabetes.
    Hudspeth B
    Am J Manag Care; 2018 Aug; 24(13 Suppl):S268-S272. PubMed ID: 30160393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
    Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
    Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of cardiovascular disease in type 2 diabetes].
    Paquot N; Scheen AJ
    Rev Med Liege; 2003 May; 58(5):271-4. PubMed ID: 12940113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.